Measures of Health Status and Quality of Life

You have full text access to this OnlineOpen article

Adult measures of general health and health-related quality of life: Medical Outcomes Study Short Form 36-Item (SF-36) and Short Form 12-Item (SF-12) Health Surveys, Nottingham Health Profile (NHP), Sickness Impact Profile (SIP), Medical Outcomes Study Short Form 6D (SF-6D), Health Utilities Index Mark 3 (HUI3), Quality of Well-Being Scale (QWB), and Assessment of Quality of Life (AQOL)

  1. Lucy Busija1,*,
  2. Eva Pausenberger2,
  3. Terry P. Haines2,
  4. Sharon Haymes1,
  5. Rachelle Buchbinder3,†,
  6. Richard H. Osborne4

Article first published online: 7 NOV 2011

DOI: 10.1002/acr.20541

Issue

Arthritis Care & Research

Arthritis Care & Research

Supplement: Special Outcomes

Volume 63, Issue Supplement S11, pages S383–S412, November 2011

Additional Information

How to Cite

Busija, L., Pausenberger, E., Haines, T. P., Haymes, S., Buchbinder, R. and Osborne, R. H. (2011), Adult measures of general health and health-related quality of life: Medical Outcomes Study Short Form 36-Item (SF-36) and Short Form 12-Item (SF-12) Health Surveys, Nottingham Health Profile (NHP), Sickness Impact Profile (SIP), Medical Outcomes Study Short Form 6D (SF-6D), Health Utilities Index Mark 3 (HUI3), Quality of Well-Being Scale (QWB), and Assessment of Quality of Life (AQOL). Arthritis Care Res, 63: S383–S412. doi: 10.1002/acr.20541

Author Information

  1. 1

    University of Melbourne, Melbourne, Victoria, Australia

  2. 2

    Southern Health, Cheltenham, Victoria, Australia, and Monash University, Melbourne, Victoria, Australia

  3. 3

    Cabrini Institute and Monash University, Melbourne, Victoria, Australia

  4. 4

    Deakin University, Melbourne, Victoria, Australia

  1. †

    Dr. Buchbinder has received speaking fees (less than $10,000 each) from Pfizer, Wyeth, Abbott, and Roche, and (more than $10,000) from Abbott for participating as an international mentor for 3e Initiative.

*Center for Eye Research Australia, Royal Victorian Eye and Ear Hospital, 32 Gisborne Street, East Melbourne, VIC 3002, Australia

  1. †

    Dr. Buchbinder has received speaking fees (less than $10,000 each) from Pfizer, Wyeth, Abbott, and Roche, and (more than $10,000) from Abbott for participating as an international mentor for 3e Initiative.

Publication History

  1. Issue published online: 7 NOV 2011
  2. Article first published online: 7 NOV 2011
  3. Manuscript Accepted: 20 JUN 2011
  4. Manuscript Received: 22 FEB 2011

Funded by

  • Centre for Eye Research Australia
  • Southern Health and Monash University Allied Health Research Unit
  • National Health and Medical Research Council Career Development Award
  • National Health and Medical Research Council Practitioner Fellowship
  • National Health and Medical Research Council Population Health Career Development Award

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS